NEW YORK (GenomeWeb) – BioMarker Strategies announced it has landed two small business innovation research (SBIR) grants from the National Cancer Institute.

The Rockville, Maryland-based companion diagnostics firm has already received a six month $300,000 Phase I grant and has recently been awarded a two year, $2 million Phase II grant to develop a companion diagnostic for non-small cell lung cancer therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.